S U M M A R Y
Background: New strains of meticillin-resistant Staphylococcus aureus (MRSA) may be associated with changes in rates of disease or clinical presentation. Conventional typing techniques may not detect new clonal variants that underlie changes in epidemiology or clinical phenotype. Aim: To investigate the role of clonal variants of MRSA in an outbreak of MRSA bacteraemia at a hospital in England. Methods: Bacteraemia isolates of the major UK lineages (EMRSA-15 and -16) from before and after the outbreak were analysed by whole-genome sequencing in the context of epidemiological and clinical data. For comparison, EMRSA-15 and -16 isolates from another hospital in England were sequenced. A clonal variant of EMRSA-16 was identified at the outbreak hospital and a molecular signature test designed to distinguish variant isolates among further EMRSA-16 strains. Findings: By whole-genome sequencing, EMRSA-16 isolates during the outbreak showed strikingly low genetic diversity (P < 1 Â 10 À6 , Monte Carlo test), compared with EMRSA-15
and EMRSA-16 isolates from before the outbreak or the comparator hospital, demonstrating the emergence of a clonal variant. The variant was indistinguishable from the
Introduction
Transmission of Staphylococcus aureus in hospitals, particularly of meticillin-resistant S. aureus (MRSA), is a global health challenge. Since its earliest detection, the epidemiology of MRSA has been characterized by the repeated emergence of new clones that expand and then decline. 1e3 In the UK, two clones designated epidemic MRSA (EMRSA)-15 [corresponding to clonal complex (CC)22 and multi-locus sequence type (ST)22] and EMRSA-16 (also known as USA200 and corresponding to CC30, ST36) became dominant in the 1990s, accounting for >95% of nosocomial MRSA infection. 4 The prevalence of both clones began declining in around 2004, EMRSA-16 at a faster rate. 5 In 2004, a large general teaching hospital in southern England (Brighton) experienced a sudden increase in rates of MRSA bacteraemia that persisted until 2007. Increases in hospital infections are often attributed to poor infection control. However, outbreaks of MRSA infection may also be caused by the importation of new strains. 6e8 In the Brighton outbreak, conventional typing methods failed to detect novel strains and showed that the nationally prevalent EMRSA-15 and EMRSA-16 strains caused 92% of bacteraemias. 9 A curious finding was that although no new lineage appeared, EMRSA-16 dominated in Brighton at a time when EMRSA-16 rates were falling nationally in relation to EMRSA-15. 4 Although failure in infection control seemed possible, it was considered unlikely since it would have most probably resulted in an increase in all bacterial strains.
In theory, clonal variants arising within epidemic MRSA strains could, like new lineages, contribute to changes in infection rate or severity. This has not been demonstrated to date. Conventional approaches to typing of S. aureus [such as typing of the spa gene or multi-locus sequence typing (MLST)] are poorly discriminatory and would be unable to detect such variation within EMRSA clones. Whole-genome sequencing has the potential to detect subclones within dominant lineages of MRSA and to reveal the genetic basis for clonal expansion and virulence. 7,10e13 We hypothesized that the emergence of a new clonal variant within EMRSA-16 might account for the outbreak in Brighton. Therefore the aim of this study was to investigate the outbreak using bacterial whole-genome sequencing, in comparison with control isolates from Oxford, where trends represented those seen in the rest of the UK.
Methods
Setting, microbiological sampling and selection of isolates for typing Isolates underwent spa-typing and meticillin-resistant isolates were assigned as EMRSA-15 (spa-type t032) or EMRSA-16 (spatypes t018) respectively. These isolates then underwent wholegenome sequencing. 9 As a control population, we wholegenome-sequenced systematically collected bacteraemia and carriage MRSA isolates from similar time-periods from the Oxford University Hospital NHS Trust (OUH), a 1600-bed general and teaching hospital in southern England, at which MRSA bacteraemia rates were close to the national average across the study period ( Figure 1) .
Based on the results of the whole-genome sequencing we subsequently tested additional available Brighton isolates collected in 2004, early in 2006 and from April 2007 to March 2011 using a molecular signature test (described below). In total, 215 Brighton MRSA isolates from individual episodes of bacteraemia between 2000 and 2011 were spa-typed, of which 82 (38%) were EMRSA-15 and 93 (45%) EMRSA-16, from which 32 and 38 whole-genome sequences were obtained respectively (online-only Figure 1 ).
Whole-genome sequencing and bioinformatics
A full description of whole-genome sequencing and analysis may be found in the online-only methods. Paired-end, indexed libraries were produced for Illumina sequencing from 1.25 mg of sample DNA. Read data were assembled de novo using Velvet, and Staphylococcal Cassette Chromosome (SCC)mec types were identified by comparison of Velvet assemblies with a panel of type-representative SCCmec sequences.
14 Reads from EMRSA-16 and -15 isolates were mapped to lineage-specific reference genomes as previously described.
15e17 The evolutionary history of each lineage was reconstructed using ClonalFrame. 18 Lineage-specific genetic insertions were identified by mapping to a library of unique S. aureus sequences obtained from GenBank. Sequence read data have been deposited with the European Nucleotide Archive under accession ERP001489.
Molecular signature typing of EMRSA-16 isolates
Having identified the variant of EMRSA-16 in Brighton, a molecular signature test was designed to identify this variant EMRSA-16 strain in isolates that had not been whole-genome sequenced. The assay targeted five single nucleotide polymorphisms (SNPs) (S1eS5) on the three branches ancestral to the Brighton EMRSA-16 clonal variant (B1-B3 in Figure 
Clinical profile of the outbreak
To assess the impact of the clonal variant on disease presentation, we compared age, sex, ward location and associated routine laboratory data (haemoglobin, neutrophil count, total white cell count, platelets, creatinine, urea, C-reactive protein and albumin) at the time of bacteraemia between the clonal variant and all other episodes of MRSA bacteraemia at Brighton during the study period. Differences were sought by ttest or ManneWhitney U-test for parametrically and nonparametrically distributed variables respectively and Fisher's exact test for differences in proportions. P 0.05 was considered significant.
Ethical approval
Isolate storage and data collection was approved in Brighton by the BSUH Research and Development office as a service evaluation, involving anonymized data from patient records and not requiring formal ethical review. Oxford 1997e1998 isolates were collected from the routine microbiology laboratory and stored without personally identifying information. remaining CC30 isolate was identified as a probable community-associated MRSA since it carried SCCmec V, was genetically distinct and was ciprofloxacin sensitive; it was excluded from further analysis. Relationships within EMRSA-16 and EMRSA-15 groups were reconstructed (Figure 2 ), using sampling times to place dates on the phylogenetic tree (details in Supplementary methods). The most recent common ancestor of EMRSA-16 strains in our sample is estimated to have occurred in 1990 (95% credible interval March 1989eFebruary 1991), coinciding closely with the reported 1991 emergence of EMRSA-16 in the UK. 20 There is strong clustering of isolates in the EMRSA-16 tree with respect to sampling time and location. The most recent common ancestor of EMRSA-15 strains in our sample is estimated to have occurred in 1994 (95% credible interval May 1993eOctober 1994) although EMRSA-15 was first described in English hospitals in 1991. 21, 22 EMRSA-15 showed no dominant local clones and few clusters with recent common ancestors (<3 years) (Figure 2 Figure 1A ). The genome of each Brighton EMRSA-16 clonal variant differed from its nearest neighbour by a median of 7 (range: 0e22) mutations. Such close genomic relationships are consistent with recent transmission and clonal expansion, i.e. rapid, recent emergence. 11 The formation of such a large cluster so quickly is highly unlikely under a standard coalescent model for the structure of an idealized population (P < 1 Â 10 À6 , by simulation). 23 
Contribution of the EMRSA-16 variant to the outbreak
To explore the contribution of the EMRSA-16 variant to the outbreak, we tested all available EMRSA-16 isolates that had not been whole-genome-sequenced using the SNP-based molecular signature test MRSA bacteraemias caused by the EMRSA-16 variant occurred in patients of all ages and throughout the hospital. There was no difference in age or sex of cases. However, the proportion of MRSA bacteraemias caused by it differed between units with a greater proportion of clonal variant MRSA bacteraemias in intensive care (19/33 MRSA bacteraemias) and a lower proportion on the renal unit (7/46) (P < 0.001). After adjustment for patient location, MRSA bacteraemia episodes caused by the variant were associated with a significantly higher total white cell count [difference þ4.0 (1.7e6.3 Â 10 9 / L); P < 0.001] and neutrophil count [þ3.9 (1.7e6.0 Â 10 9 /L); P < 0.001] than episodes caused by non-variant strains (nonvariant EMRSA-16, EMRSA-15 and other strains) with 40% of variant cases having neutrophil counts >15 Â 10 9 /L versus only 14% of the other strains. Platelet count was also higher in episodes caused by the variant [difference þ62 (15e108 Â 10 9 /L); P ¼ 0.009]. There was no significant difference in other laboratory values including C-reactive protein (see online-only tables).
Genomic innovations associated with the EMRSA-16 clonal variant
We sought genomic events (mutation, homologous recombination, gain or loss of gene content) on the branches of the phylogeny ancestral to the variant (B1, B2, B3 in Figure 2 ) that might explain its emergence via a selectively favoured change in phenotype. Twenty-five point mutations (21 nonsynonymous, 11 non-synonymous substitutions on B3, the branch immediately ancestral to the clonal expansion) were identified across the three branches, including two nonsynonymous changes in ebh, a gene encoding a very large cell wall-associated fibronectin-binding protein consistent with patterns recently reported among EMRSA-16 strains in which this gene was hypothesized to have an effect on virulence. 12, 24 A 5.3 kb homologous recombination event was detected on B2 ( Figure 2 ) which shows high similarity to regions of the (phi)Sa3 family phage in the MRSA252 upstream of the regions encoding the PantoneValentine Leucocidin (PVL) genes. In addition 3.2 kb of unique sequences (termed 'BE' in Figure 2 ) were identified, variants of which had also inserted on other parts of the EMRSA-16 tree. BE comprises part of a larger (w20 kb) fragment of a phiNM4-like phage sequence whose position could not be uniquely determined using short-read data.
Discussion
Nosocomial infection rates, particularly those for MRSA bacteraemia, are regarded as key indicators of infection control effectiveness. 25 Not only do nosocomial infections have significant impact on patient outcomes, but high rates may also adversely affect reputation, leading to loss of revenue, and further declines in quality. 26 The emergence of novel pathogen strains may influence disease epidemiology. 6, 7 One challenge with clonal organisms such as S. aureus is that conventional methods may fail to detect the emergence of novel variants within major lineages, although it is plausible that such variants could influence rates and severity of disease. Advances in microbial whole-genome sequencing make it possible for the first time to detect variants of epidemic MRSA strains and assess their impact. 7 We applied whole-genome sequencing to investigate a three-year hospital outbreak of MRSA bacteraemia and demonstrated the emergence of a clonal variant of an epidemic MRSA lineage that was undetectable using conventional genotyping. The appearance of the variant coincided with the onset of the outbreak in 2004, and accounted for virtually all EMRSA-16 isolates by the peak of the outbreak. MRSA bacteraemia rates began to decline in 2007, possibly as a result of intensive infection control measures, although no specific additional intervention was made. The variant caused bacteraemias in patients of all ages and throughout the hospital. It was most prevalent in intensive care and gastroenterology units. Bacteraemias caused by the variant were associated with higher neutrophil counts than other MRSA bacteraemias. There are several possible explanations for this since the neutrophil response to an infection depends on the immune status of the patient and the source of the infection.
One explanation for the emergence of the variant is that one or more genomic innovations may have conferred a selective advantage leading to the clonal expansion. Although our data do not definitively demonstrate that the clonal variant caused the outbreak, the counter explanation that it was a feature of the outbreak also indicates a transmission advantage of the variant within it. Relatively small fitness advantages may have a substantial impact on transmission, might be specific to a local environment and could relate to several aspects of bacterial ecology, for example, the reported interaction between microbial genetics and infection control practice in the selection of chlorhexidine resistance in MRSA. 27, 28 Other studies have demonstrated the impact of new clones on the epidemiology of S. aureus infection within specific hospital units; our data indicate dissemination across different units within the hospital. 7, 8 As whole-genome sequencing enters clinical practice we will come to understand how often new clonal variants emerge within healthcare settings and how often this is associated with clinically significant changes in disease phenotype or transmission. Our failure to identify a specific genetic explanation for the emergence of the variant is consistent with reports describing the difficulty of establishing a causal link retrospectively. 18, 29 The potential relationship between mutations in ebh or the recombination events and higher neutrophil counts in bacteraemia caused by the clonal variant requires further investigation.
Another potential explanation for the appearance of the variant is a 'founder effect', in which a breakdown in infection control allowed the emergence of a randomly selected strain which was not typical of the ancestral population. However, it is unlikely that this would preferentially favour a single clone and could alone explain the outbreak. Furthermore, it seems unlikely that a single MRSA lineage would have expanded across the entire hospital by chance, surpassing other prevalent MRSA lineages. Similarly, a lapse in infection control specific to a single unit is not compatible with the presence of the variant across the hospital. Staff were not screened for MRSA during the period of the outbreak, so we cannot exclude the possible involvement of one or more healthcare workers in distributing the variant. Further studies of the role of healthcare workers in nosocomial transmission of S. aureus are warranted.
A limitation of this study is its dependence on archived isolates: as such the sampling time-frame is interrupted. Although this impedes precision in plotting the time-course of the outbreak, the use of time-scaled phylogenies means that it does not undermine the central observation.
Microbial whole-genome sequencing is providing insights into the national and international spread of MRSA lineages. 11, 12, 30 This technology is entering clinical practice and has the potential to be applied rapidly enough to influence patient care. 7, 8 Our study demonstrates the emergence of a clonal variant within a nosocomial epidemic MRSA lineage associated with an outbreak. If, at the time of the outbreak, we had been using whole-genome sequencing for routine surveillance, the novel variant would have been recognized, allowing targeted investigation of transmission routes and sources, and the initiation of evidence-based control measures. This study demonstrates the potential for whole-genome sequencing to improve understanding of the epidemiology of MRSA within hospitals.
